TH171341A - Pharmaceutical constituents containing pyridyl aminoacetic acid compounds. And polyoxyethylene castor oil - Google Patents

Pharmaceutical constituents containing pyridyl aminoacetic acid compounds. And polyoxyethylene castor oil

Info

Publication number
TH171341A
TH171341A TH1601004016A TH1601004016A TH171341A TH 171341 A TH171341 A TH 171341A TH 1601004016 A TH1601004016 A TH 1601004016A TH 1601004016 A TH1601004016 A TH 1601004016A TH 171341 A TH171341 A TH 171341A
Authority
TH
Thailand
Prior art keywords
castor oil
acid compounds
polyoxyethylene castor
aminoacetic acid
constituents containing
Prior art date
Application number
TH1601004016A
Other languages
Thai (th)
Other versions
TH171341B (en
Inventor
เอ็นโดะ โยโกะ
Original Assignee
นางดารานีย์ วัจนะวุฒิวงศ์
นางสาวสนธยา สังขพงศ์
Filing date
Publication date
Application filed by นางดารานีย์ วัจนะวุฒิวงศ์, นางสาวสนธยา สังขพงศ์ filed Critical นางดารานีย์ วัจนะวุฒิวงศ์
Publication of TH171341B publication Critical patent/TH171341B/en
Publication of TH171341A publication Critical patent/TH171341A/en

Links

Abstract

สิทธิบัตรยา Drug patent

Claims (1)

: ข้อถือสิทธิ์ (ข้อที่หนึ่ง) ซึ่งจะปรากฏบนหน้าประกาศโฆษณา : แก้ไข 02/11/2561 หน้า 1 ของจำนวน 4 หน้า ข้อถือสิทธิ: The right (item one) which will appear on the advertisement page: Amendment 02/11/2018 Page 1 of 4 pages. 1. องค์ประกอบทางเภสัชกรรมที่ประกอบรวมด้วยไอโซโพรพิล (6-{[4-(ไพราโซล-1- อิล)เบนซิล](ไพริดิน-3-อิลซัลโฟนิล)อะมิโนเมทิล}ไพริดินแท็ก : สิทธิบัตรยา1. Pharmaceutical components containing isopropyl (6 - {[4- (pyrazol-1-il) benzyl] (pyridin-3-ilsulfonyl) aminomethyl) pyridin Tag: drug patent
TH1601004016A 2015-01-08 Pharmaceutical constituents containing pyridyl aminoacetic acid compounds. And polyoxyethylene castor oil TH171341A (en)

Publications (2)

Publication Number Publication Date
TH171341B TH171341B (en) 2017-12-07
TH171341A true TH171341A (en) 2017-12-07

Family

ID=

Similar Documents

Publication Publication Date Title
TH171341A (en) Pharmaceutical constituents containing pyridyl aminoacetic acid compounds. And polyoxyethylene castor oil
TH1701004077A (en) Active substance for improving early insulin secretion capacity.
TH1801001808A (en) An isoindolinone inhibitor of MDM2-P53 interaction with anticancer activity.
TH1801001807A (en) An isoindolinone inhibitor of MDM2-P53 interaction with anticancer activity.
TH1701002032A (en) The use of neridronic acid or its salts for the treatment of osteomyelitis.
TH1701005228A (en) Kv1.3 inhibitors and their medical applications
TH1701005119A (en) Bicyclic pyridine compound
TH1701005229A (en) Kv1.3 inhibitors and their medical applications
TH1501005494A (en) Inhibitors of the kinurenine pathway
TH1701003724A (en) Pharmaceutical constituents for cancer treatment containing metal lactate salts.
TH1701005921A (en) Substances used to treat dry eye syndrome Which includes the nandrolone or esters of this Or methinolone, or esters of this As an active ingredient
TH151210A (en) Pyridox alkaloids that inhibit malaria pathogens.
TH1701003406A (en) Pharmaceutical formulation of tropomieosin-related kinase inhibitors (TRK).
TH1701002473A (en) Immune regulating agents
TH1601004234A (en) Pharmaceutical constituents containing IgM
TH1701004149A (en) Skin care products containing HERMETIA ILLUCENS extract
TH1701001067A (en) Pharmaceutical components and therapeutic combinations containing substances Inhibits cholesterol-transmitted proteins and HMG CoA reductase inhibitors.
TH1701002548A (en) Long-acting pharmaceutical constituents for hepatitis C
TH180207A (en) Improved stability of glucagon derivatives (GLUCAGON DERIVATIVES).
TH1701006437A (en) Azabenzimidazole and its use as AMPA receptor modulator.
TH1501005024A (en) Pharmaceutical constituents for the treatment of fungal infections.
TH1701006519A (en) A solid form of a compound in which modulated kinase.
TH166749A (en) New pyrolopyrimidine compounds Or salt of that substance Pharmaceuticals containing the same substance, in particular for the prevention and / or treatment of tumors and others that rely on NAE inhibitory effects.
TH1701001893A (en) Heteroeryl compounds are inhibitors of BTK and their uses.
TH1701006047A (en) Insecticide useful molecules and media, their constituents and processes related to them.